The award recognizes the application of tissue engineering and regenerative medicine in the production of a product or technology that ultimately will benefit patients.
Individuals living with type 1 diabetes must carefully follow prescribed insulin regimens every day, receiving injections of the hormone via syringe, insulin pump or some other device. And without viable long-term treatments, this course of treatment is a lifelong sentence.
A team of researchers at Northwestern University have discovered a technique to help make immunomodulation more effective. The method used nanocarriers to re-engineer the commonly used immunosuppressant rapamycin.